行情

OCX

OCX

ONCOCYTE
NASDAQ

实时行情|Nasdaq Last Sale

1.060
+0.040
+3.92%
交易中 11:01 05/27 EDT
开盘
1.020
昨收
1.020
最高
1.060
最低
1.010
成交量
5.70万
成交额
2.84万
52周最高
6.25
52周最低
0.9700
市值
1.26亿
市盈率(TTM)
-1.3795
分时
5日
1月
3月
1年
5年
暂无数据
暂无数据
了解OCX最新的财务预测,通过OCX每股收益,每股净资产,每股现金流等数据分析ONCOCYTE近期的经营情况,然后做出明智的投资选择。
分析师评级

7位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

28.57%强力推荐
57.14%买入
14.29%中性
0.00%落后大盘
0.00%卖出
目标价格预测
分析师预测OCX价格均价为3.275,最高价位6.00,最低价为1.400。
最高6.00
均价3.275
最低1.400
现价1.060
EPS
实际EPS
预期EPS
-0.12-0.09-0.06-0.03
Q2 2021
Q3 2021
Q4 2021
Q1 2022
Q2 2022
机构持股
总机构数: 112
机构持股: 5,871.68万
持股比例: 49.54%
总股本: 1.19亿
类型机构数股数
增持
28
232.75万
建仓
11
41.56万
减持
30
222.22万
平仓
17
164.79万
  • 业绩
  • 资产分布
  • 分红历史
暂无数据
所属板块
生物技术和医学研究
+2.04%
制药与医学研究
+0.44%
高管信息
Non-Executive Chairman/Independent Director
Andrew Arno
President/Chief Executive Officer/Director
Ronald Andrews
Chief Financial Officer
Mitchell Levine
Chief Operating Officer
Gisela Paulsen
Chief Accounting Officer/Vice President/Controller
Li Yu
Other
Douglas Ross
Other
Padma Sundar
Independent Director
Jennifer Carter
Independent Director
Melinda Griffith
Independent Director
Alfred Kingsley
Independent Director
Andrew Last
Independent Director
Cavan Redmond
暂无数据
暂无数据
OCX 简况
Oncocyte Corporation is a molecular diagnostics company. The Company is engaged in developing and commercializing laboratory-developed tests (LDTs) to serve unmet medical needs across the cancer care continuum. The LTDs provide actionable information to physicians and patients to optimize treatment decisions, including the selection of immunotherapy. The Company focuses on the development of a non-invasive confirmatory blood test for lung cancer called DetermaDx. The DetermaDx is the test to predict a post-surgery patient’s risk of cancer recurrence and their response to chemotherapy in early-stage lung cancer. Its development pipeline includes TheraSure CNI Monitor, which is a blood-based test for immunotherapy monitoring, and TheraSure Transplant Monitor, a solid organ transplantation monitoring test. Its other DetermaIO, DetermaCNI, DetermaMx, Keytruda, Opdivo, Tecentriq and Imfinzi.

微牛提供OncoCyte Corp(NASDAQ-OCX)的股票价格、实时市场报价、专业分析师评级、深度图表和免费的OCX股票新闻,以帮助您做出投资决策。

模拟交易:模拟炒股免费实操交易技能。您可用虚拟资金在真实市场环境中零成本、零风险体验交易OCX股票基本功能。